Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 1/20 | 0.54 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.54 |
| ▸ | AHCY | P23526 | 7/20 | 0.52 |
| ▸ | HSP90B1 | P14625 | 3/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.49 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.49 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.49 |
| ▸ | GAPDH | P04406 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.49 |
| ▸ | STAT6 | P42226 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3978671 | 1.00 | PRMT5 (0.54) | PRMT5WDR77AHCYHSP90B1ADORA2A | |
| SCHEMBL3978681 | 1.00 | PRMT5 (0.54) | PRMT5WDR77AHCYHSP90B1ADORA2A | |
| SCHEMBL29712359 | 1.00 | PRMT5 (0.54) | PRMT5WDR77AHCYHSP90B1ADORA2A | |
| SCHEMBL13844404 | 0.84 | PRMT5 (0.61) | PRMT5WDR77AHCYADORA2AADORA2B | |
| Nonactin SCHEMBL8750347 | 0.82 | PRMT5 (0.44) | PRMT5WDR77AHCYHSP90B1ADORA2A | |
| SCHEMBL15828310 | 0.81 | P2RX1 (0.63) | ADORA1SMN1; SMN2 | |
| SCHEMBL15828228 | 0.81 | P2RX1 (0.63) | ADORA1SMN1; SMN2 | |
| SCHEMBL31725331 | 0.78 | AHCY (0.53) | PRMT5WDR77AHCYHSP90B1ADORA2A | |
| SCHEMBL21015672 | 0.78 | AHCY (0.50) | AHCYADORA2BSLC28A1SLC28A2 | |
| SCHEMBL25390968 | 0.78 | ADORA3 (0.57) | PRMT5WDR77AHCYADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160158261-A1 | Antibiotic Kit and Composition and Uses Thereof | FOAMIX LTD. (IL) | 2016-06-09 | — | — | US | claimed |
| US-9211259-B2 | Antibiotic kit and composition and uses thereof | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-12-15 | — | — | US | claimed |
| EP-1919449-A2 | ANTIBIOTIC KIT AND COMPOSITION AND USES THEREOF | Foamix Ltd. (IL) | 2008-05-14 | — | — | EP | claimed |
| WO-2007099396-A2 | ANTIBIOTIC KIT AND COMPOSITION AND USES THEREOF | FOAMIX LTD. (US) | 2007-09-07 | — | — | WO | claimed |
| US-20060269485-A1 | Antibiotic kit and composition and uses thereof | FOAMIX LTD. (IL) | 2006-11-30 | — | — | US | claimed |
| US-20260109675-A1 | COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260103696-A1 | COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4674476-A1 | MAGNETIC FIELD VARIATION THERAPY FOR ENHANCING THERAPEUTIC AND DISINFECTION APPLICATIONS | Azyro SA (LU) | 2026-01-07 | — | — | EP | disclosed |
| US-12496310-B2 | Compositions and methods for adoptive cell therapy | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2025-12-16 | — | — | US | disclosed |
| EP-3802850-B1 | DEVICES AND SYSTEMS FOR GASTROINTESTINAL MICROBIOME DETECTION AND MANIPULATION | BT BIDCO INC (US) | 2025-11-19 | — | — | EP | disclosed |
| EP-3645561-B1 | COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2025-05-07 | — | — | EP | disclosed |
| US-20250082265-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNOSUPPRESSANT | BT BIDCO, INC. | 2025-03-13 | — | — | US | disclosed |
| EP-0129285-B1 | PENETRATING TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING N-(2-HYDROXYETHYL)PYRROLIDONE | THE PROCTER & GAMBLE COMPANY (US) | 1991-05-15 | — | — | EP | disclosed |
| US-4900407-A | Method for deoxygenation of alcohols | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1990-02-13 | — | — | US | disclosed |
| EP-0238672-A1 | PROCESS FOR DEOXIDIZING ALCOHOL | Yamasa Shoyu Kabushiki Kaisha (JP) | 1987-09-30 | — | — | EP | disclosed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | disclosed |
| US-4537776-A | PERCUTANEOUS DELIVERY OF ANTIINFLAMMATORY AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1985-08-27 | — | — | US | disclosed |
| EP-0129285-A2 | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl)pyrrolidone | THE PROCTER & GAMBLE COMPANY (US) | 1984-12-27 | — | — | EP | disclosed |
| EP-0129284-A2 | Improved penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one | THE PROCTER & GAMBLE COMPANY (US) | 1984-12-27 | — | — | EP | disclosed |
| US-3928319-A | 4 -Fluoro nucleosides, novel intermediates and methods of preparing same | SYNTEX INC | 1975-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103696-A1 | COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER | CCRL2, CCR3, LY6K | PRMT5 3522/4885WDR77 395/4885AHCY 1098/4885 |
| US-12496310-B2 | Compositions and methods for adoptive cell therapy | HAVCR2, CD4, CCR1 | PRMT5 3921/4885WDR77 1819/4885AHCY 174/4885 |
| US-20250082265-A1 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNOSUPPRESSANT | TPMT, FABP2, SLC10A2 | PRMT5 3166/4885WDR77 3872/4885AHCY 241/4885 |
| US-20260109675-A1 | COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER | IL2RA, CCR3, CD4 | PRMT5 3295/4885WDR77 1101/4885AHCY 1148/4885 |
| US-20160158261-A1 | Antibiotic Kit and Composition and Uses Thereof | KIT, RAB5IF, CUTA | PRMT5 3835/4885WDR77 400/4885AHCY 3908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.